Company / Income Tax per Share
Krystal Biotech, Inc. Income Tax per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax per Share
-$0.53
FY2025
5-year range
-$0.53 / $0.22
FY2021-FY2025
Trend
-343.1%
vs FY2024
Sector context
#196 of 201
Health Care
What the data says
Income Tax per Share changed -343% YoY in FY2025, a notable deviation from the 2-year average annual change of -78%.
Based on SEC 10-K filings.
-0.53 in FY2025.
Improved from $0.08 to $-0.53 over the past 2 years.
Health Care sector context is included.
Income Tax per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 201This company -$0.53 Sector average $1.35
▼
-139.6% below sector average
Key checks
Key Insights
- In FY2025, income tax per share decreased 343.1% year-over-year.
- Ranks #196 out of 201 companies in the Health Care sector.
- Peak income tax per share was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 5.66 (safe zone, above 2.9 threshold)
- Strong profit margin: 30.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income Tax per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.53 | -343.1% |
| FY2024 | $0.22 | +187.7% |
| FY2023 | $0.08 | - |
| FY2022 | $0.00 | - |
| FY2021 | $0.00 | - |
| FY2020 | $0.00 | - |
| FY2019 | $0.00 | - |
| FY2018 | $0.00 | - |
| FY2017 | $0.00 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026